Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients

Reporting results of cancer treatment

1981 • 7,916 citations

A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer

1991 • 260 citations

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy

1987 • 155 citations

Phase-II study of Navelbine in advanced breast cancer.

1989 • 132 citations

Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.

1988 • 131 citations

Experimental antitumor activity of Navelbine.

1989 • 127 citations

A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine-type alkaloids

1979 • 96 citations

Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.

1989 • 91 citations

Phase I pharmacologic study of a new Vinca alkaloid: Navelbine

1985 • 80 citations

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.

1986 • 73 citations

Multicenter Phase II trial of etoposide in refractory small cell lung cancer.

1985 • 38 citations

Second line chemotherapy in small cell lung cancer

1989 • 28 citations

Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).

1984 • 18 citations

Good clinical practice: a way to better drugs.

1989 • 9 citations